• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Trop Med Hyg . Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea

tetano

Editor, Senior Moderator
Am J Trop Med Hyg


. 2022 Feb 25;tpmd210713.
doi: 10.4269/ajtmh.21-0713. Online ahead of print.
Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea


Mory Keita[SUP] 1 2 [/SUP], Mahamoud Sama Cherif[SUP] 3 [/SUP], Billy Sivahera[SUP] 4 [/SUP], Samuel T Boland[SUP] 5 [/SUP], Freddy Banza-Mutoka[SUP] 1 [/SUP], Mamadou Kourouma[SUP] 4 [/SUP], Alseny Modet Camara[SUP] 6 [/SUP], Youssouf Sidibe[SUP] 7 [/SUP], Jean Paul Kimenyi[SUP] 1 [/SUP], Lamine Diassy[SUP] 4 [/SUP], Angelo Loua[SUP] 8 [/SUP], Ibrahima Sory Fofana[SUP] 4 [/SUP], Youba Kandako[SUP] 4 [/SUP], Dobo Onivogui[SUP] 9 [/SUP], Enogo Koivogui[SUP] 10 [/SUP], Tamba Jacques Millimono[SUP] 10 [/SUP], Fode Diakite[SUP] 4 [/SUP], Mamadou Balde[SUP] 4 [/SUP], Bienvenu Houndjo[SUP] 4 [/SUP], Ngoy Nsenga[SUP] 1 [/SUP], Ambrose Talisuna[SUP] 1 [/SUP], Alexandre Delamou[SUP] 3 11 [/SUP], Olivia Keiser[SUP] 2 [/SUP], Georges Alfred Ki-Zerbo[SUP] 4 [/SUP], Abdou Salam Gueye[SUP] 1 [/SUP]



Affiliations

Abstract

In this case report, we describe a clinical presentation and therapeutic history of a unique case diagnosed with Lassa fever and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 23-year-old man from Yomou prefecture in southeast Guinea identified with suspected Ebola Virus Disease (EVD) in the midst of an ongoing outbreak of that disease in the same region. On May 3, 2021, he was admitted to the Nzérékoré Epidemic disease treatment center where his clinical condition deteriorated significantly. Laboratory testing performed on the same day reveals a negative EVD polymerase chain reaction (PCR). Three days later, the patient was tested positive for SARS-CoV-2 and Lassa fever by reverse transcriptase PCR (RT-PCR) assays. Laboratory examination also indicated severe hematological and biochemical deteriorations in the patient. This case substantiates the need for systematic differential diagnosis during epidemic-prone disease outbreaks to better manage severely unwell patients.
 
Back
Top Bottom